Glenmark Pharmaceuticals Limited has informed the Exchange about ESG Rating.
GLENMARK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Glenmark Pharmaceuticals has been assigned an ESG (Environmental, Social, and Governance) rating of 68 for FY 2025 by NSE Sustainability Ratings and Analytics Limited. The rating was assigned independently by NSE Sustainability based on publicly available information, and the company clarified that it did not engage or commission NSE Sustainability for this assessment. The disclosure is being made under SEBI's Listing Regulations to keep exchanges and investors informed.
An ESG rating of 68 is a moderate-to-good score that may be viewed positively by ESG-focused institutional investors, potentially improving Glenmark's appeal in sustainability-themed funds. However, since the company did not seek the rating and it was based solely on public data, it carries limited direct financial impact on the stock price.